Pravin R. Chaturvedi, Ph.D.
Chief Scientific Officer
Dr. Chaturvedi is the President and Chief Scientific Officer of Napo Pharmaceuticals and has nearly 20 years of pharmaceutical industry experience.
He has been associated with the discovery and development of several novel drugs for the treatment of a variety of diseases.
Over his career, Dr. Chaturvedi has been a part of the development of five marketed drugs and of several new drugs undergoing clinical evaluation. Most recently, Dr. Chaturvedi was the Founder & CEO of IndUS Pharmaceuticals, Inc., an emerging pharmaceutical company, focused on the discovery and development of novel small molecule drugs for the treatment of cancer, diabetes and infectious diseases. Prior to founding IndUS Pharmaceuticals, Dr. Chaturvedi was the founding President & CEO of Scion Pharmaceuticals, a company focused on the discovery and development of new drugs targeting ion channels for the treatment of central nervous system (CNS), cardiovascular (CV) and urological disorders. Prior to Scion, Dr. Chaturvedi, spent several years at Vertex Pharmaceuticals, where he was the Head of Lead Evaluation and participated successfully in the discovery and development of several new antiviral, oncology, immunosuppressive and anti-inflammatory drugs. Prior to Vertex, Dr. Chaturvedi was in the preclinical group at Alkermes, where he participated in CNS and oncology product development and prior to that, he was in the Product Development group at Parke-Davis/Warner-Lambert Company, where he worked on the development of new drugs for the treatment of oncology, epilepsy, pain and cognition. Dr. Chaturvedi holds a Ph.D. in Pharmaceutical Sciences from West Virginia University and a Bachelor's in Pharmacy from the University of Bombay.